Salvia BioElectronics has raised 26 million euros ($30 million) in new financing to fund development of a neurostimulation therapy for chronic migraine.
Medical device company Indigo Diabetes has raised 38 million euros to develop an “invisible” sensor for people with diabetes, which could provide an alternative to the “patch” based monitor